OptiNose device

· Optinose US Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for OptiNose device, covering 2018-01-24 to 2018-01-24. Get the full timeline:

Most recent: Clinical Trial Update: 12-Month OL Intranasal Fluticasone Propionate BID Using OptiNose Device [Phase 3]